(Q34627053)

English

Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

systematic review

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

Hideaki Shimada

1

object named as

Hideaki Shimada

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Shinichi Okazumi

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Masamichi Koyama

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Koji Murakami

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

18 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

13-21

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

An analysis of the physiological FDG uptake pattern in the stomach

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Improving evaluation of primary gastric malignancies by distending the stomach with milk immediately before 18F-FDG PET scanning

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Gastrointestinal tract malignancies and positron emission tomography: an overview

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Staging and follow-up of gastrointestinal tumors with PET/CT.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Early detection of recurrence after endoscopic treatment for early gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Imaging in assessing lymph node status in gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Usefulness of preoperative FDG-PET for detection of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Whole-body PET with FDG for the diagnosis of recurrent gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

The role of PET/CT in detection of gastric cancer recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Detecting recurrence of gastric cancer: the value of FDG PET/CT.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Prevalence of positive FDG-PET findings in patients with high CEA levels

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

FDG-PET has no definite role in preoperative imaging in gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Cancer screening using 18F-FDG PET/CT in Korean asymptomatic volunteers: a preliminary report

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

The efficacy of preoperative PET/CT for prediction of curability in surgery for locally advanced gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-011-0017-5

21 January 2018

Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Has the accuracy of preoperative diagnosis improved in cases of early-stage gastric cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCCN task force: clinical utility of PET in a variety of tumor types

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnostic value of PET-CT for peritoneal dissemination of abdominal malignancies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of the physiological FDG uptake in the stomach with the water gastric distention method

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peritoneal carcinomatosis: role of (18)F-FDG PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is PET-CT suitable for predicting lymph node status for gastric cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21331531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10120-011-0017-5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34627053&oldid=2196884668"